Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Atavistik Bio, Inc
Seagen Inc.
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Washington University School of Medicine
Sensei Biotherapeutics, Inc.
Jonsson Comprehensive Cancer Center
Revolution Medicines, Inc.
Elevation Oncology
UNC Lineberger Comprehensive Cancer Center
Cedars-Sinai Medical Center
Universitair Ziekenhuis Brussel
M.D. Anderson Cancer Center
Genmab
Kineta Inc.
Revolution Medicines, Inc.
University Health Network, Toronto
Revolution Medicines, Inc.
Imperial College London
Instituto do Cancer do Estado de São Paulo
Instituto do Cancer do Estado de São Paulo
Mayo Clinic
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Duke University
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
ImmunoFrontier, Inc.
St. Luke's-Roosevelt Hospital Center
New Mexico Cancer Research Alliance
Astellas Pharma Inc